4//SEC Filing
JOHNSON FRANKLIN P JR 4
Accession 0001181431-05-002559
CIK 0000318154other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 1:17 PM ET
Size
7.7 KB
Accession
0001181431-05-002559
Insider Transaction Report
Form 4
AMGEN INCAMGN
JOHNSON FRANKLIN P JR
Director
Transactions
- Exercise/Conversion
Common Stock
2005-01-10$7.67/sh+18,400$141,163→ 898,622 total - Exercise/Conversion
NQSO (Right to Buy)
2005-01-10−18,400→ 0 totalExercise: $7.67From: 1995-01-27Exp: 2005-01-27→ Common Stock (18,400 underlying)
Footnotes (1)
- [F1](FPJ 01.10.05) Does not include (i) 634,400 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner, (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0000904017
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 1:17 PM ET
- Size
- 7.7 KB